Updated: 2010-07-23 16:48:44
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:41
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:37
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:36
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:35
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:35
Founded in 1980, Mary Ann Liebert, Inc. is universally acknowledged for establishing authoritative peer-reviewed journals in the most promising areas of biotechnology, biomedical research/life sciences, clinical medicine and surgery, and law.
Updated: 2010-07-23 16:48:34
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:32
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:32
Founded in 1980, Mary Ann Liebert, Inc. is universally acknowledged for establishing authoritative peer-reviewed journals in the most promising areas of biotechnology, biomedical research/life sciences, clinical medicine and surgery, and law.
Updated: 2010-07-23 16:48:30
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:27
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:25
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:23
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:21
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:20
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-23 16:48:16
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-22 05:01:30
(Beyond Pesticides, July 22, 2010) In a press release submitted last week, the Monsanto Company, Inc. announced that it has taken a vital step towards commercializing a new soybean product that is tolerant to the neurotoxic pesticide dicamba by completing its regulatory submission to the U.S. Department of Agriculture (USDA) for dicamba-tolerant soybeans. Monsanto expects [...]
Updated: 2010-07-21 13:08:19
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2010-07-19 05:01:08
(Beyond Pesticides, July 19, 2010) The Washington D.C. based Center for Food Safety (CFS) has unveiled an application for mobile phones to help shoppers quickly and easily identify foods made with ingredients from genetically modified (GM) organisms. Many consumers are leery of GM foods, yet unfortunately producers are not required to label products that contain [...]
Updated: 2010-07-18 06:29:27
Razib Khan points to a projection for the rate at which full human genome DNA sequencing will be done over the next 10 years. The firm GenomeQuest has a blog, and on that blog they have a post, Implications of exponential growth of global whole genome sequencing capacity. In that post there are some bullet points with numbers. Here they are: * 2001-2009: A Human Genome * 2010: 1,000 Genomes Learning the Ropes * 2011: 50,000 Genomes Clinical Flirtation * 2012: 250,000 Genomes Clinical Early Adoption * 2013: 1 Million Genomes Consumer Awareness * 2014: 5 Million Genomes Consumer Reality * 2015-2020: 25 Million Genomes And Beyond A Brave New World In light of...
Updated: 2010-07-16 06:58:29
The FDA wants to get more involved in controlling the genetic testing industry. In a prelude to overhauling its regulatory oversight of genetic diagnostic testing, the U.S. Food and Drug Administration will convene a public meeting next week to gather input from test makers and others. I would prefer the FDA and like regulatory agencies stay out of genetic testing except perhaps to test for error rates and publish the results. The rate of innovation will be faster with less regulatory involvement. Yes, genetic testing will serve as a cornerstone of personalized medicine - but only if it is allowed to grow rapidly without big costs involved in getting regulatory approvals. The event reflects a turning point in genetic testing,...
Updated: 2010-07-16 04:48:13
Biotechnology from bench to business log in register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products